Biography and Research Information
OverviewAI-generated summary
Katherine Cruse's research investigates mechanisms to improve cancer immunotherapy. Her work has focused on manipulating the DNA damage response to address T cell exhaustion, a common barrier to effective immunotherapy. Additionally, she has studied how donor-intrinsic proteomic programs influence CAR-T cell persistence, a critical factor in the success of this cell-based therapy. Cruse collaborates with researchers at the University of Arkansas for Medical Sciences, including Brian Koss, Jessica L. Kelliher, Daniel Fil, and Lora J. Rogers, with whom she shares multiple publications.
Metrics
- Publications: 2
Selected Publications
-
236 Manipulating the DNA damage response to combat T cell exhaustion and improve immunotherapy response (2025)
-
392 Donor-intrinsic proteomic programs shape CAR-T cell persistence across a longitudinal killing assay (2025)
Collaboration Network
Top Collaborators
- 392 Donor-intrinsic proteomic programs shape CAR-T cell persistence across a longitudinal killing assay
- 236 Manipulating the DNA damage response to combat T cell exhaustion and improve immunotherapy response
- 392 Donor-intrinsic proteomic programs shape CAR-T cell persistence across a longitudinal killing assay
- 236 Manipulating the DNA damage response to combat T cell exhaustion and improve immunotherapy response
- 392 Donor-intrinsic proteomic programs shape CAR-T cell persistence across a longitudinal killing assay
- 236 Manipulating the DNA damage response to combat T cell exhaustion and improve immunotherapy response
- 392 Donor-intrinsic proteomic programs shape CAR-T cell persistence across a longitudinal killing assay
- 236 Manipulating the DNA damage response to combat T cell exhaustion and improve immunotherapy response
- 392 Donor-intrinsic proteomic programs shape CAR-T cell persistence across a longitudinal killing assay
- 236 Manipulating the DNA damage response to combat T cell exhaustion and improve immunotherapy response
- 236 Manipulating the DNA damage response to combat T cell exhaustion and improve immunotherapy response
- 236 Manipulating the DNA damage response to combat T cell exhaustion and improve immunotherapy response
- 236 Manipulating the DNA damage response to combat T cell exhaustion and improve immunotherapy response
- 236 Manipulating the DNA damage response to combat T cell exhaustion and improve immunotherapy response
- 236 Manipulating the DNA damage response to combat T cell exhaustion and improve immunotherapy response
- 236 Manipulating the DNA damage response to combat T cell exhaustion and improve immunotherapy response
Similar Researchers
Based on overlapping research topics